Catheter Precision, Inc. (NYSE:VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., a subsidiary of Creatd, Inc. (OTCQB:CRTD), marking an expansion of the company's portfolio investments. The transaction allows Creatd to advance its strategy of building a diversified holding company of technology-enabled operating businesses while preserving Fly Flyte's independent operations and management structure.
Fly Flyte specializes in providing AI-enabled regional aviation services with a focus on enhancing accessibility and convenience for travelers. The company operates within the growing segment of technology-driven aviation services, positioning itself at the intersection of artificial intelligence applications and regional air transportation. The investment reflects VTAK's interest in aerospace and technology-enabled service providers.
The minority stake acquisition demonstrates continued activity in the aerospace technology sector, where companies are increasingly leveraging artificial intelligence to optimize operations and improve customer experience. The terms of the transaction and specific valuation details were not disclosed in the announcement.